Dow Down 1.40% Nasdaq Down 1.59%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
355.61 4.91(1.36%) Oct 1, 4:00PM EDT
|After Hours : 353.75 Down 1.86 (0.52%) Oct 1, 7:54PM EDT
Prev Close:360.52
Open:363.95
Bid:347.00 x 200
Ask:356.00 x 300
1y Target Est:369.47
Beta:0.65
Earnings Date:Nov 3 - Nov 7 (Est.)
Day's Range:352.91 - 363.95
52wk Range:257.69 - 369.31
Volume:669,386
Avg Vol (3m):789,908
Market Cap:35.70B
P/E (ttm):101.20
EPS (ttm):3.51
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Related Video

Headlines

» More Headlines for REGN

Comparison

Symbol% ChgMkt Cap
REGNDown 1.36%35.70B
AMGN105.45B
NVS226.17B
RHHBY249.64B

Key Statistics

Forward P/E (1 yr):28.82
P/S (ttm):14.48
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :10.12
Quarterly EPS Est (Sep-14) :2.57
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.77

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions in the United States and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback